genprowebdirectory
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2023
Exelixis
Artificial Intelligence
StockWatch: Insilico CEO Breaks Down Exelixis Deal
Alex Philippidis
-
September 25, 2023
0
Drug Discovery
Ipsen Partnering with Exelixis to Develop Cabozantinib
GEN Staff Writer
-
March 1, 2016
0
Cancer
Phase III Study Shows Exelixis’ Cabozantinib Nearly Triples PFS in Metastatic Medullary Thyroid Cancer
GEN Staff Writer
-
June 5, 2012
0
Cancer
Exelixis Broadens Cabozantinib Program Through CRADA with NCI-CTEP
GEN Staff Writer
-
May 3, 2012
0
Cancer
Exelixis to Raise $160M in Financing Deals with Silicon Valley Bank and Deerfield Management
GEN Staff Writer
-
June 3, 2010
0
News
Bristol-Myers Squibb Exercises Option to Develop Another Exelixis Drug Candidate
GEN Staff Writer
-
November 24, 2008
0
News
GSK Ends Alliance with Exelixis with Decision Not to Select Another Compound
GEN Staff Writer
-
October 23, 2008
0
Scroll Up